Cardioprotection against endotoxins

对抗内毒素的心脏保护作用

基本信息

  • 批准号:
    7069035
  • 负责人:
  • 金额:
    $ 25.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A number of studies have shown that rodents submitted to a mild whole body heat shock become resistant to a subsequent lethal dose of lipopolysaccharides (LPS). It is still unclear how a pre-heat treatment protects against endotoxins but one of the main results of a heat shock is the increased synthesis of a group of proteins known as the heat shock proteins (hsp). The hsp70 is the most abundant of these hsps and has been postulated to be the principal mediator of the observed protection against LPS. Since one of the majors consequences of endotoxemia is the induction of myocardial contractile dysfunction and hsp70 has been previously shown to protect against myocardial dysfunction due to infarction. We therefore propose to investigate the mechanism by which the hsp70 protects the myocardium during endotoxemia. Our preliminary results show that heat shocked isolated rat neonatal cardiomyocytes are tolerant to a subsequent exposure to LPS. In addition, cardiomyocytes infected with adenoviral vectors containing the hsp70 gene are also tolerant to endotoxin exposure in vitro. We also find that a transgenic mouse line overexpressing a hsp70 gene is more tolerant to endotoxemia than littermates that do not express the hsp70 transgene. The mechanism in which hsp70 renders the cardiomyocyte both in vitro and in vivo tolerant to endotoxemic injury would seem to involve a reduction in inducible nitric oxide synthase expression according to our preliminary results. We therefore propose to study in both isolated cardiomyocytes and the heart tissue of transgenic mice, the level of the mediators of endotoxin-induced cell injury: TNF-alpha, IL-1, nitric oxide (NO), inducible NO synthase and the transcription factor NFkB and how they are affected by the increased presence of hsp70. The proposed research project should clearly demonstrate if the sole presence of increased levels of hsp70 is protective against endotoxemia. This proposed study may open the way to harness the endogenous protective mechanisms in cardiomyocytes and to new innovative and effective therapies against the myocardial depression caused by endotoxins.
描述(由申请人提供):许多研究表明,遭受轻度全身热休克的啮齿动物对随后致死剂量的脂多糖(LPS)产生抗性。目前尚不清楚预热处理是如何防止内毒素的,但热休克的主要结果之一是一组被称为热休克蛋白(hsp)的蛋白质的合成增加。hsp70是这些热休克蛋白中最丰富的,被认为是观察到的抗LPS保护的主要介质。由于内毒素血症的主要后果之一是诱发心肌收缩功能障碍,hsp70先前已被证明可防止梗死引起的心肌功能障碍。因此,我们建议研究hsp70在内毒素血症中保护心肌的机制。我们的初步结果表明,热休克分离大鼠新生心肌细胞耐受随后暴露于LPS。此外,用含有hsp70基因的腺病毒载体感染的心肌细胞在体外也能耐受内毒素暴露。我们还发现,过表达hsp70基因的转基因小鼠比不表达hsp70基因的小鼠对内毒素血症的耐受性更强。根据我们的初步结果,hsp70使体外和体内心肌细胞耐受内毒素损伤的机制似乎与诱导型一氧化氮合酶表达的减少有关。因此,我们建议在分离的心肌细胞和转基因小鼠的心脏组织中研究内毒素诱导细胞损伤的介质:tnf - α、IL-1、一氧化氮(NO)、诱导型NO合成酶和转录因子NFkB的水平,以及它们如何受到hsp70存在增加的影响。拟议的研究项目应清楚地证明,是否单独存在的hsp70水平的增加是对内毒素血症的保护。本研究为心肌细胞内源性保护机制的研究开辟了新的途径,为内毒素引起的心肌抑制提供了新的创新和有效的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RUBEN MESTRIL其他文献

RUBEN MESTRIL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RUBEN MESTRIL', 18)}}的其他基金

Cardioprotection against endotoxins
对抗内毒素的心脏保护作用
  • 批准号:
    6769959
  • 财政年份:
    2003
  • 资助金额:
    $ 25.29万
  • 项目类别:
Cardioprotection against endotoxins
对抗内毒素的心脏保护作用
  • 批准号:
    6895802
  • 财政年份:
    2003
  • 资助金额:
    $ 25.29万
  • 项目类别:
Cardioprotection against endotoxins
对抗内毒素的心脏保护作用
  • 批准号:
    6669618
  • 财政年份:
    2003
  • 资助金额:
    $ 25.29万
  • 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
  • 批准号:
    6390093
  • 财政年份:
    2000
  • 资助金额:
    $ 25.29万
  • 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
  • 批准号:
    6619566
  • 财政年份:
    2000
  • 资助金额:
    $ 25.29万
  • 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
  • 批准号:
    6192642
  • 财政年份:
    2000
  • 资助金额:
    $ 25.29万
  • 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
  • 批准号:
    6527373
  • 财政年份:
    2000
  • 资助金额:
    $ 25.29万
  • 项目类别:
STRESS PROTEIN 60 DURING MYOCARDIAL ISCHEMIA
心肌缺血期间的应激蛋白 60
  • 批准号:
    2211222
  • 财政年份:
    1994
  • 资助金额:
    $ 25.29万
  • 项目类别:
STRESS PROTEIN 60 DURING MYOCARDIAL ISCHEMIA
心肌缺血期间的应激蛋白 60
  • 批准号:
    2211221
  • 财政年份:
    1994
  • 资助金额:
    $ 25.29万
  • 项目类别:
STRESS PROTEIN 60 DURING MYOCARDIAL ISCHEMIA
心肌缺血期间的应激蛋白 60
  • 批准号:
    2211220
  • 财政年份:
    1994
  • 资助金额:
    $ 25.29万
  • 项目类别:

相似海外基金

Cell fate determination technique by single cell morphology design using gel-micromachining technique
使用凝胶微加工技术通过单细胞形态设计确定细胞命运的技术
  • 批准号:
    23K17723
  • 财政年份:
    2023
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Optimizing triple negative breast cancer therapy based on immune cell morphology
基于免疫细胞形态优化三阴性乳腺癌治疗
  • 批准号:
    468140
  • 财政年份:
    2022
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Operating Grants
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
  • 批准号:
    RGPIN-2018-05756
  • 财政年份:
    2022
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Discovery Grants Program - Individual
Comprehensive and multi-resolution mapping of cell morphology and wiring through X-ray holographic nano-tomography
通过 X 射线全息纳米断层扫描对细胞形态和布线进行全面的多分辨率绘图
  • 批准号:
    10376584
  • 财政年份:
    2021
  • 资助金额:
    $ 25.29万
  • 项目类别:
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
  • 批准号:
    RGPIN-2018-05756
  • 财政年份:
    2021
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Discovery Grants Program - Individual
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
  • 批准号:
    RGPIN-2018-05756
  • 财政年份:
    2020
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Discovery Grants Program - Individual
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
  • 批准号:
    RGPIN-2018-05756
  • 财政年份:
    2019
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Discovery Grants Program - Individual
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
  • 批准号:
    DGECR-2018-00147
  • 财政年份:
    2018
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Discovery Launch Supplement
Enabling mammalian in vivo forward genetic screens based on cell morphology
实现基于细胞形态的哺乳动物体内正向遗传筛选
  • 批准号:
    9754850
  • 财政年份:
    2018
  • 资助金额:
    $ 25.29万
  • 项目类别:
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
  • 批准号:
    RGPIN-2018-05756
  • 财政年份:
    2018
  • 资助金额:
    $ 25.29万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了